SOUTH SAN FRANCISCO, Calif.,
Feb. 12, 2020 /PRNewswire/ -- Portola
Pharmaceuticals, Inc.® (NASDAQ: PTLA) today announced
that it will host a webcast and conference call to discuss the
Company's financial results for the fourth quarter and full year
ended December 31, 2019, and provide
a general business overview, on Wednesday, February 26, 2020,
at 4:30 p.m. ET (1:30 p.m.
PT).
Conference Call Details
The live conference call
on Wednesday, February 26, 2020, at 4:30 p.m. ET, can be
accessed by phone by calling (844) 452-6828 from the United
States and Canada or 1 (765) 507-2588
internationally and using the passcode 6192918. The webcast can be
accessed live on the Investor Relations section of the Company's
website at http://investors.portola.com. It will be archived
for 30 days following the call.
About Portola Pharmaceuticals, Inc.
Portola
Pharmaceuticals is a global, commercial-stage biopharmaceutical
company focused on the discovery, development and commercialization
of novel therapeutics that could significantly advance the fields
of thrombosis and other hematologic conditions. The Company's first
two commercialized products are Andexxa® [coagulation
factor Xa (recombinant), inactivated-zhzo], marketed in
Europe as Ondexxya®
(andexanet alfa), and Bevyxxa® (betrixaban). The company
also is advancing cerdulatinib, a SYK/JAK inhibitor being developed
for the treatment of hematologic cancers. Founded in 2003 in
South San Francisco, California,
Portola has operations in
the United States and Europe.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/portola-pharmaceuticals-to-announce-fourth-quarter-and-full-year-2019-financial-results-on-wednesday-february-26-2020-301003228.html
SOURCE Portola Pharmaceuticals, Inc.®